IB
Universal Ibogaine Inc.
IBOGF · OTC
$0.00 N/A (+$0.00)
1M -96.09%
Market Cap $11.5M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
34 /100
Fair P/B 2.92x
P/S 10.75x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 171.46%
Rev. growth N/A
FCF growth N/A
Profitability
50 /100
Moderate Net margin 980.22%
Op. margin 46.43%
FCF margin 413.60%
Quality
30 /100
Poor ROA 166.14%
Asset turnover 0.17x
ROIC 8.70%
Debt
73 /100
Low Current ratio 1.60x
Int. coverage 0.00x
Net debt/EBITDA -0.22x
Stability
1 /100
Unstable EPS volatility 105.25%
Profitable years 0
Beta 4.38x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o IBOGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Nicholas Peter Karos
Employees
7
Headquarters
Calgary